Business Context and Reporting Period
Company: Astro-Med, Inc. (Note: Input metadata referenced "Astronova," but the filing is for Astro-Med, Inc.)
Filing Type: Form 10-K Annual Report
Period Ended: January 31, 2003
Business Overview: Astro-Med designs, develops, manufactures, and distributes technology-advanced products across three segments: Test & Measurement (T&M), QuickLabel Systems (QLS), and Grass-Telefactor (G-T). The company serves aerospace, automotive, manufacturing, and life sciences markets globally, with approximately 27% of sales derived from international operations.
Key Financial Metrics
| Metric | Fiscal 2003 | Fiscal 2002 |
|---|---|---|
| Net Sales | $48.97 million | $49.39 million |
| Gross Profit | $18.09 million | $19.11 million |
| Gross Margin | 36.9% | 38.7% |
| Operating Loss | $(1.59) million | $(0.73) million |
| Net Loss | $(1.88) million | $(0.23) million |
| Loss Per Share (Basic/Diluted) | $(0.44) | $(0.05) |
| Working Capital | $18.83 million | $21.46 million |
| Total Assets | $35.21 million | $38.40 million |
| Cash & Marketable Securities | $7.34 million | $5.91 million |
| Long-Term Debt | $0 | $0 |
| Operating Cash Flow | $2.68 million | $1.28 million |
Material Changes vs. Prior Period
- Revenue Stability: Net sales declined slightly by 0.9% to $48.97 million. Domestic sales increased 1.0%, while international sales decreased 5.1%.
- Profitability Decline: The company reported a net loss of $1.88 million compared to a net loss of $0.23 million in the prior year. This was driven by a 5.3% decrease in gross profit and increased operating expenses.
- Restructuring Charges: The company recorded $0.49 million in restructuring and impairment charges, including $0.36 million in severance and $0.13 million in asset write-downs, following a workforce reduction of 28 employees (8% of total workforce).
- Tax Provision: A significant tax expense of $0.82 million was recorded due to the establishment of a full valuation allowance for deferred tax assets, reversing a prior tax benefit.
- Segment Performance:
- T&M: Sales down 1%; margin improved to 8.5% due to favorable sales mix.
- QLS: Sales up 3%; margin collapsed to 0.5% due to a shift toward lower-margin consumable media sales and away from printer systems.
- Grass-Telefactor: Sales down 5.5%; margin declined to 2.0% primarily due to restructuring charges.
Outlook, Risks, and Contingencies
- Liquidity: The company maintains a $2.0 million unsecured bank line of credit, all of which is currently available. Management expects to finance future needs through internal funds.
- Dividends: The company paid an annual dividend of $0.16 per share and anticipates continuing this policy.
- Accounting Changes: The company adopted SFAS No. 142 (Goodwill) and SFAS No. 146 (Exit Costs). The adoption of SFAS 109 led to a full valuation allowance on deferred tax assets due to cumulative losses.
- Contingencies: An earn-out provision from the 1999 Telefactor acquisition could require up to $3.0 million in additional payments if sales targets are met over 72 months; no amount was owed as of January 31, 2003.
- Risks: Key risks include declining demand in defense/aerospace markets, competition in specialty printing, foreign currency exchange rate fluctuations, and the ability to realize cost reductions from restructuring.
Investor Verification Checklist
- Valuation Allowance: Verify the sustainability of the full valuation allowance on deferred tax assets and its impact on future tax benefits.
- Segment Mix: Assess the long-term impact of the shift in QLS sales from high-margin printers to low-margin consumables on overall profitability.
- Restructuring Savings: Monitor whether the anticipated $2.0 million in annual cost savings from the workforce reduction is realized in subsequent quarters.
- International Exposure: Review the impact of foreign currency fluctuations on the 27% of revenue generated outside the U.S.
- Goodwill Impairment: Confirm the status of goodwill ($2.31 million) assigned to T&M and G-T segments under SFAS 142.